Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study

Castro, Nicoly Marques de; Moura, Fernando; Hada, Aline Lury; Garcia, Diogo; Victor, Elivane da Silva; Schvartsman, Gustavo; Carvalho, Leonardo; Fernandes, Milena Lourenço Coleta; Martins, Rodrigo de Souza; Silva, Elaine Ferreira da; Santos, Sarah Silva Mello Batista dos; Taniwaki, Letícia; Taranto, Patrícia; Pontes, Janaina; Beal, Juliana Rodrigues; Dutra, Ana Carolina Pereira; Oliveira, João Bosco de; Araujo, Sérgio Eduardo Alonso; Usón, Pedro Luiz Serrano

doi:10.31744/einstein_journal/2024ao0575

Einstein (São Paulo)

2024

DOI: 10.31744/einstein_journal/2024ao0575

|View full text |Cite

Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study

Nicoly Marques de Castro,

Fernando Moura,

Aline Lury Hada

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Publication Types

Select...

Relationship

Self Cite0

Independent0

Authors

Journals

Cited by 0 publications

References 35 publications

(40 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

No citations

Set email alert for when this publication receives citations?

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Prognostic value of programmed cell death ligand 1 (PD-L1) expression in patients with stage III non-small cell lung cancer under different treatment types: a retrospective study

Cited by 0 publications

References 35 publications

No citations

Contact Info

Product

Resources

About